IP Library Granted Patent US 12,183,001
Granted Patent B2
US 12,183,001 · App. 18/063,616 · Granted Dec 31, 2024

Content based image retrieval for lesion analysis

Inventors: Daniel Irving Golden (Palo Alto, CA); Fabien Rafael David Beckers (San Francisco, CA); John Axerio-Cilies (Berkeley, CA); Matthieu Le (San Francisco, CA); Jesse Lieman-Sifry (San Francisco, CA); Anitha Priya Krishnan (Foster City, CA); Sean Patrick Sall (Indianapolis, IN); Hok Kan Lau (San Francisco, CA); Matthew Joseph Didonato (Redwood City, CA); Robert George Newton (Calgary, CA); Torin Arni Taerum (Calgary, CA); Shek Bun Law (Calgary, CA); Carla Rosa Leibowitz (San Carlos, CA); Angélique Sophie Calmon (Montauban, FR)
Assignee: Arterys Inc.
G06T7/0012G06N3/08G06T7/11G06V10/82G16H10/60G06T2207/10081G06T2207/20081G06T2207/20084G06T2207/30056G06T2207/30064G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,183,001
App. No.
18/063,616
Granted
Dec 31, 2024
Kind
B2
Abstract

Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) are commonly used to assess patients with known or suspected pathologies of the lungs and liver. In particular, identification and quantification of possibly malignant regions identified in these high-resolution images is essential for accurate and timely diagnosis. However, careful quantitative assessment of lung and liver lesions is tedious and time consuming. This disclosure describes an automated end-to-end pipeline for accurate lesion detection and segmentation.

Claims (48)

1. A machine learning system, comprising:

at least one nontransitory processor-readable storage medium that stores at least one of processor-executable instructions or data, a trained convolutional neural network (CNN) model, a database that stores batches of image data that depict potentially cancerous lesions and their associated features, and query data for a query potentially cancerous lesion, the query data including image data and a set of associated features; and

at least one processor communicably coupled to the at least one nontransitory processor-readable storage medium, in operation, the at least one processor:

extracts features from the image data of the query potentially cancerous lesion utilizing the trained CNN model and includes the extracted features in the set of associated features of the query potentially cancerous lesion;

calculates a similarity of the query potentially cancerous lesion to one or more potentially cancerous lesions in the database based on at least a subset of the set of associated features of the query potentially cancerous lesion;

retrieves a plurality of potentially cancerous lesions from the database ranked by similarity to the query potentially cancerous lesion; and

causes presentation of the plurality of potentially cancerous lesions by performing at least one of:

causing displaying of the plurality of potentially cancerous lesions in stratified sections each corresponding to a different lesion type;

causing displaying of the plurality of potentially cancerous lesions in a multi-dimensional polar plot representing multiple dimensions of similarity; or

causing displaying of the plurality of potentially cancerous lesions with gaps separating one from another, wherein the gaps are calculated based on respective similarities between corresponding potentially cancerous lesions.

2. The machine learning system of claim 1 wherein the at least one processor calculates the similarity based on a mathematical determination of distance between the features of the query potentially cancerous lesion and the features of the potentially cancerous lesions in the database.

3. The machine learning system of claim 2 wherein the at least one processor calculates the similarity using at least one of the Euclidian distance, the Manhattan distance, the Minkowski distance, or the LP distance (with P>0), between the features of the query potentially cancerous lesion and the features of the potentially cancerous lesions in the database.

4. The machine learning system of claim 2 wherein the determination of distance between the features further comprises using one or more user preferences at inference time or at training time.

5. The machine learning system of claim 2 wherein the at least one processor selects similar lesions based on an approximate nearest neighbors algorithm.

6. A method, comprising:

extracting features from image data of a query potentially cancerous lesion utilizing a trained convolutional neural network (CNN) model and including the extracted features in a set of associated features of the query potentially cancerous lesion;

calculating a similarity of the query potentially cancerous lesion to one or more potentially cancerous lesions in a database based on at least a subset of the set of associated features of the query potentially cancerous lesion;

retrieving a plurality of potentially cancerous lesions from the database ranked by similarity to the query potentially cancerous lesion; and

causing presentation of the plurality of potentially cancerous lesions by performing at least one of:

causing displaying of the plurality of potentially cancerous lesions in stratified sections each corresponding to a different lesion type;

causing displaying of the plurality of potentially cancerous lesions in a multi-dimensional polar plot representing multiple dimensions of similarity; or

causing displaying of the plurality of potentially cancerous lesions with gaps separating one from another, wherein the gaps are calculated based on respective similarities between corresponding potentially cancerous lesions.

7. The method of claim 6 , wherein the retrieved potentially cancerous lesions from the database are based on a stratification of one or more associated features.

8. The method of claim 7 wherein the associated features used for stratification are based on histopathological assessment from biopsies of the potentially cancerous lesions.

9. The method of claim 8 wherein at least one of the associated features used for stratification is whether or not the potentially cancerous lesion was determined to be cancerous.

10. The method of claim 6 wherein retrieving the one or more potentially cancerous lesions from the database comprises retrieving only the potentially cancerous lesions that are most similar to the query potentially cancerous lesion or retrieving only the potentially cancerous lesions that are drawn from patients who are clinically or demographically similar to the patient from whom the query potentially cancerous lesion is drawn.

11. The method of claim 6 , further comprising causing presentation of the retrieved potentially cancerous lesions sorted by their similarity to the query potentially cancerous lesion to a user on a display.

12. The method of claim 6 , further comprising causing presentation of an indication of similarity or distance with respect to the query potentially cancerous lesion overlaid over or placed alongside the potentially cancerous lesions to a user on a display.

13. The method of claim 6 , further comprising causing presentation of lesions that are determined to be cancerous in a different section than lesions that are determined to be benign to a user on a display.

14. The method of claim 6 , further comprising causing presentation of an indication of whether the lesion has been determined to be benign or malignant using a color, symbol, or textual indication overlaid over or placed alongside the potentially cancerous lesion to a user on a display.

15. The method of claim 6 , further comprising causing presentation of results obtained from a biopsy for cancerous lesions using a color, symbol, or textual indication overlaid over or placed alongside the potentially cancerous lesion to a user on a display.

16. The method of claim 6 , further comprising causing presentation of features that are dissimilar between the query lesion and the retrieved lesions to a user on a display.

17. The method of claim 6 , further comprising classifying the query potentially cancerous lesion using a classification model based on associated features and diagnostic information for the K most similar retrieved potentially cancerous lesions that have associated diagnostic information.

18. The method of claim 17 wherein the output of the classification is (a) whether the potentially cancerous lesions are benign or malignant or (b) a cancer subtype of the potentially cancerous lesions.

19. A non-transitory computer-readable medium storing contents that, when executed by one or more processors, cause performance of actions comprising:

extracting features from image data of a query potentially cancerous lesion utilizing a trained convolutional neural network (CNN) model and including the extracted features in a set of associated features of the query potentially cancerous lesion;

calculating a similarity of the query potentially cancerous lesion to one or more potentially cancerous lesions in a database based on at least a subset of the set of associated features of the query potentially cancerous lesion;

retrieving a plurality of potentially cancerous lesions from the database ranked by similarity to the query potentially cancerous lesion; and

causing presentation of the plurality of potentially cancerous lesions by performing at least one of:

causing displaying of the plurality of potentially cancerous lesions in stratified sections each corresponding to a different lesion type;

causing displaying of the plurality of potentially cancerous lesions in a multi-dimensional polar plot representing multiple dimensions of similarity; or

causing displaying of the plurality of potentially cancerous lesions with gaps separating one from another, wherein the gaps are calculated based on respective similarities between corresponding potentially cancerous lesions.

20. The computer-readable medium of claim 19 wherein calculating the similarity comprises using a regression model whose output is a similarity score for at least some of the potentially cancerous lesions in the database.

21. The computer-readable medium of claim 20 wherein the features used as input to the regression model include one or more of image features extracted by a CNN or clinical features.

22. The computer-readable medium of claim 19 wherein the actions further comprise modifying the calculation of the similarity based on a user's feedback regarding the relative similarity of the retrieved results.

23. The computer-readable medium of claim 22 wherein the actions further comprise receiving input from the user to (a) indicate which results are similar or dissimilar, or (b) re-order results based on their preference for similarity.

24. The computer-readable medium of claim 19 wherein the actions further comprise causing presentation of results of the retrieving as part of a software package whose indications for use include the facilitation of diagnosis planning and biopsy planning for lesions observed in radiological images.

25. The computer-readable medium of claim 24 wherein the radiological images are acquired (a) for a purpose of cancer screening or (b) for a purpose of examining one or more potentially cancerous lesions that were known to exist or suspected to exist prior to acquisition of the radiological images.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded May 14, 2026
From: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
To: TEMPUS AI, INC. (F/K/A TEMPUS LABS, INC.)
Reel/Frame 074653/0745 →
SECURITY INTEREST Recorded May 25, 2023
From: TEMPUS LABS, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 063764/0174 →
Continuity (8)
Continuation 16766539
Provisional Application 62589805 · Nov 22, 2017
Provisional Application 62589772 · Nov 22, 2017
Provisional Application 62589872 · Nov 22, 2017
Provisional Application 62589876 · Nov 22, 2017
Provisional Application 62589833 · Nov 22, 2017
Provisional Application 62589838 · Nov 22, 2017
Related Publication 20230106440A1 · Apr 6, 2023
Cited By (1)
US 12,664,656